Literature DB >> 27240836

Non-IgE-Dependent Hypersensitivity to Rocuronium Reversed by Sugammadex: Report of Three Cases and Hypothesis on the Underlying Mechanism.

David Spoerl1, Stéphanie D'Incau, Pascale Roux-Lombard, Thomas Harr, Christoph Czarnetzki.   

Abstract

We present 3 cases of pseudoallergic (anaphylactoid) reactions to perioperatively administered rocuronium, which rapidly resolved after sugammadex injection. Allergological workup showed no evidence for immediate-type hypersensitivity to the drugs used for anesthesia, including rocuronium. However, rocuronium induced an irritative reaction in skin tests in all 3 patients and in 3 healthy individuals. This reaction was specifically suppressed by adding sugammadex at a 1:1 molecular proportion to rocuronium before the skin tests. This observation suggests that the patients suffered from a pseudoallergic reaction, and indicates that sugammadex might act via the inhibition of non-IgE mediated MRGPRX2 (Mas-related G-protein-coupled receptor member X2)-triggered mast cell degranulation induced by rocuronium.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27240836     DOI: 10.1159/000446182

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  6 in total

Review 1.  Update on Quinolone Allergy: A Complementary Note.

Authors:  Athina L Van Gasse; Vito Sabato; Margaretha Faber; Margo M Hagendorens; Didier G Ebo
Journal:  Curr Allergy Asthma Rep       Date:  2017-10-03       Impact factor: 4.806

Review 2.  Multifaceted MRGPRX2: New insight into the role of mast cells in health and disease.

Authors:  Saptarshi Roy; Chalatip Chompunud Na Ayudhya; Monica Thapaliya; Vishwa Deepak; Hydar Ali
Journal:  J Allergy Clin Immunol       Date:  2021-05-04       Impact factor: 14.290

Review 3.  Reclassifying Anaphylaxis to Neuromuscular Blocking Agents Based on the Presumed Patho-Mechanism: IgE-Mediated, Pharmacological Adverse Reaction or "Innate Hypersensitivity"?

Authors:  David Spoerl; Haig Nigolian; Christoph Czarnetzki; Thomas Harr
Journal:  Int J Mol Sci       Date:  2017-06-07       Impact factor: 5.923

Review 4.  In Vitro Diagnosis of Immediate Drug Hypersensitivity Anno 2017: Potentials and Limitations.

Authors:  I I Decuyper; E A Mangodt; A L Van Gasse; K Claesen; A Uyttebroek; M Faber; V Sabato; C H Bridts; C Mertens; M M Hagendorens; L S De Clerck; Didier G Ebo
Journal:  Drugs R D       Date:  2017-06

5.  MRGPRX2 Activation by Rocuronium: Insights from Studies with Human Skin Mast Cells and Missense Variants.

Authors:  Chalatip Chompunud Na Ayudhya; Aetas Amponnawarat; Saptarshi Roy; Carole A Oskeritzian; Hydar Ali
Journal:  Cells       Date:  2021-01-15       Impact factor: 6.600

Review 6.  Unlocking the Non-IgE-Mediated Pseudo-Allergic Reaction Puzzle with Mas-Related G-Protein Coupled Receptor Member X2 (MRGPRX2).

Authors:  Mukesh Kumar; Karthi Duraisamy; Billy-Kwok-Chong Chow
Journal:  Cells       Date:  2021-04-27       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.